Advanced search
Publication Cover
Journal of Medical Economics Volume 20, 2017 - Issue 6
Submit an article Journal homepage
552
Views
3
CrossRef citations to date
0
Altmetric
Cardiovascular

The cost of warfarin treatment for stroke prevention in patients with non-valvular atrial fibrillation in Russia from a collective perspective

J. B. BriereBayer Pharma AG, Berlin, Germany; Correspondence[email protected]
,
K. BowrinBayer Pharma AG, Berlin, Germany;
,
R. WoodAdelphi Real World, Macclesfield, UK;
,
J. RobertsAdelphi Real World, Macclesfield, UK;
&
B. TatarskyLaboratory Research of Arrhythmology Federal Almazov North-West Medical Research Centre, St. Petersburg, Russia
Pages 599-605 | Received 12 Dec 2016, Accepted 31 Jan 2017, Published online: 23 Feb 2017

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Mounir Bouame, Mohamed Ali Lahmar, Mohamed Tahar Bouafia, Naima Hammoudi, Mohamed Tayeb Chentir, Mouloud Ait Athmane, Saïd Kara, Matthieu Trancart, Levent Yildiz, Jerome Cheynel & Redouane Soualmi. (2018) Economic burden of thromboembolic and hemorrhagic complications in non-valvular atrial fibrillation in Algeria (the ELRAGFA study). Journal of Medical Economics 21:12, pages 1213-1220.
Read now

Articles from other publishers (2)

Swee Kee Tan, Wan Lin Looi & Hui Yee Yeo. (2020) Estimation of direct medical costs of warfarin, dabigatran and rivaroxaban treatments in non‐valvular atrial fibrillation patients in a tertiary public hospital, Malaysia. Journal of Pharmacy Practice and Research 50:5, pages 406-412.
Crossref
Amber L Martin, Alessandra G Reeves, Samantha E Berger, Manuela Di Fusco, Gail D Wygant, Mirko Savone, Kassandra Snook, Mina Nejati & Tereza Lanitis. (2019) Systematic review of societal costs associated with stroke, bleeding and monitoring in atrial fibrillation. Journal of Comparative Effectiveness Research 8:14, pages 1147-1166.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.